ID S1348

Prescribers or their delegates must review a patient's prescription drug history for the preceding 12 months from the prescription drug monitoring program before issuing outpatient prescriptions for opioid analgesics or benzodiazepines in Schedule II, III, or IV controlled substances.

The prescriber must evaluate the prescription drug history data for indicators of prescription drug diversion or misuse.

The prescription drug history review requirement does not apply to patients receiving inpatient treatment, emergency care, ambulance transport, hospice care, or skilled nursing facility care.

The requirement does not apply to prescriptions in quantities intended to last no more than 3 days.

The new requirement becomes effective October 1, 2020, and applies only to individuals required to register for the prescription drug monitoring program.